Verhey FRJ - Search Results

1

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.

Lleó A, Alcolea D, Martínez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimón J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K. Lleó A, et al. Among authors: verhey frj. Alzheimers Dement. 2019 Jun;15(6):742-753. doi: 10.1016/j.jalz.2019.01.015. Epub 2019 Apr 6. Alzheimers Dement. 2019. PMID: 30967340

2

Characteristics of preclinical Alzheimer's disease.

Visser PJ, Verhey FR, Ponds RW, Jolles J. Visser PJ, et al. Int J Geriatr Psychiatry. 2002 Jan;17(1):88-9. doi: 10.1002/gps.511. Int J Geriatr Psychiatry. 2002. PMID: 11802238 No abstract available.

3

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.

Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Visser PJ, et al. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7. doi: 10.1136/jnnp.72.4.491. J Neurol Neurosurg Psychiatry. 2002. PMID: 11909909 Free PMC article.

4

Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.

Visser PJ, Verhey FR, Scheltens P, Cruts M, Ponds RW, Van Broeckhoven CL, Jolles J. Visser PJ, et al. J Neurol. 2002 Mar;249(3):312-9. doi: 10.1007/s004150200011. J Neurol. 2002. PMID: 11993532 Clinical Trial.

5

Combination of serum markers related to several mechanisms in Alzheimer's disease.

Teunissen CE, Lütjohann D, von Bergmann K, Verhey F, Vreeling F, Wauters A, Bosmans E, Bosma H, van Boxtel MP, Maes M, Delanghe J, Blom HJ, Verbeek MM, Rieckmann P, De Bruijn C, Steinbusch HW, de Vente J. Teunissen CE, et al. Neurobiol Aging. 2003 Nov;24(7):893-902. doi: 10.1016/s0197-4580(03)00005-8. Neurobiol Aging. 2003. PMID: 12928047 Clinical Trial.

6

Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.

Rasquin SM, Lodder J, Visser PJ, Lousberg R, Verhey FR. Rasquin SM, et al. Dement Geriatr Cogn Disord. 2005;19(2-3):113-9. doi: 10.1159/000082662. Epub 2004 Dec 9. Dement Geriatr Cogn Disord. 2005. PMID: 15591801 Free article.

7

Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.

Visser PJ, Scheltens P, Pelgrim E, Verhey FR; Dutch ENA-NL-01 Study Group. Visser PJ, et al. Dement Geriatr Cogn Disord. 2005;19(2-3):126-33. doi: 10.1159/000082883. Epub 2004 Dec 23. Dement Geriatr Cogn Disord. 2005. PMID: 15627759

8

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

Visser PJ, Scheltens P, Verhey FR. Visser PJ, et al. J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1348-54. doi: 10.1136/jnnp.2004.047720. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170074 Free PMC article. Clinical Trial.

9

Ten-year risk of dementia in subjects with mild cognitive impairment.

Visser PJ, Kester A, Jolles J, Verhey F. Visser PJ, et al. Neurology. 2006 Oct 10;67(7):1201-7. doi: 10.1212/01.wnl.0000238517.59286.c5. Neurology. 2006. PMID: 17030753 Clinical Trial.

10

Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.

Visser PJ, Verhey FR. Visser PJ, et al. Psychol Med. 2008 Jan;38(1):113-22. doi: 10.1017/S0033291707000554. Epub 2007 Apr 24. Psychol Med. 2008. PMID: 17451628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

459 results

Search Page